tirzepatide to semaglutide dose conversion transitioning from transitioning from semaglutide to tirzepatide dosing Tirzepatide (MOUNJARO®/ZEPBOUND) vs Semaglutide (OZEMPIC®/WEGOVY®) Switching from tirzepatide to semaglutide

Klinic offers comprehensive assistance with semaglutide insurance coverage, right from benefit verification to managing the prior authorization process

As an added bonus, making these healthier choices can help support your long-term weight loss goals

Our goal is not just a number on the scale

Semaglutide is the active ingredient in Wegovy, an FDA-approved medication thats changing the landscape of weight management

Semaglutide activates GLP-1 receptors approximately three times more effectively than liraglutide

Weeks 1-4: 2.5 mg once weekly Weeks 5-8: 5 mg once weekly Weeks 9-12: 7.5 mg once weekly Weeks 13-16: 10 mg once weekly Weeks 17-21: 12.5 mg once weekly Weeks 21-24: 15 mg once weekly